All relevant data are within the paper and its Supporting Information files. All RNA-seq raw reads files are available from the NCBI SRA database (accession number PRJNA393246).

Introduction {#sec001}
============

A superior performance of the lactic acid bacterium (LAB) *Lactobacillus sakei* in meat fermentation has been explained by its genomic and physiological adaptions to the raw-meat environment \[[@pone.0187542.ref001]\]. The bacterium is useful in industrial meat fermentation, where important attributes for starter cultures are effective growth and high acidification activity. *L*. *sakei* is strictly fermentative, completely devoid of a respiratory chain, however, still aerotolerant \[[@pone.0187542.ref001], [@pone.0187542.ref002]\]. Depending on the growth condition, the bacterium can shift between a pathway leading to nearly exclusively lactate production versus a pathway leading to the production of mixed acids. In general, homofermentative LAB convert carbohydrates into lactate using the Embden-Meyerhof pathway (EMP). As a bacterial substrate, meat contains a restricted amount and diversity of carbohydrates, mostly consisting of low-levels of glucose derived from glycogen. Therefore, exogenous glucose is often added to speed up and improve the ripening process of fermented meat products. Hexose fermentation in *L*. *sakei* is homolactic and proceeds via EMP, resulting in formation of lactic acid and subsequent decrease in pH \[[@pone.0187542.ref001]--[@pone.0187542.ref003]\]. Heterofermentative LAB use the phosphoketolase pathway (PKP), which is often used by LAB to ferment pentoses \[[@pone.0187542.ref004]\]. In meat, ribose is also available, mostly derived from ATP hydrolysis, and is fermented via the heterolactic PKP in *L*. *sakei* \[[@pone.0187542.ref002], [@pone.0187542.ref003]\]. Reflecting the ability to metabolize meat components such as proteins, *L*. *sakei* has a comprehensive set of transporters \[[@pone.0187542.ref001], [@pone.0187542.ref005], [@pone.0187542.ref006]\]. An efficient utilization of nucleosides closely linked with the uptake and catabolic machinery of ribose \[[@pone.0187542.ref001], [@pone.0187542.ref003], [@pone.0187542.ref007]--[@pone.0187542.ref009]\], and conversion of certain amino acids such as arginine through the arginine deiminase (ADI) pathway \[[@pone.0187542.ref010], [@pone.0187542.ref011]\], provides this species with additional energy sources and thus competitive advantages in the meat environment.

The study of bacteria at a defined growth rate can be achieved in the chemostat \[[@pone.0187542.ref012]\], in which the specific growth rate is directly manipulated by changing the dilution rate, creating a controlled and constant environment, so-called steady-state. In the present work, we grew two strains of *L*. *sakei* in anaerobic, glucose-limited chemostats at two different growth rates, where fast and slow growth demonstrate adaption to glucose availability, which in many organisms results in a shift in metabolic strategy that generates less ATP per glucose in situations with high glucose availability \[[@pone.0187542.ref013]--[@pone.0187542.ref016]\]. We chose to study *L*. *sakei* strain 23K, originally isolated from sausage \[[@pone.0187542.ref017]\], and the commercial starter culture strain LS25 from fermented sausage \[[@pone.0187542.ref018]\] for three reasons. First, both strains have publicly available genome sequences \[[@pone.0187542.ref001], [@pone.0187542.ref019]\]. Second, the strains represent the two different *L*. *sakei* subspecies, *carnosus* and *sakei*, respectively \[[@pone.0187542.ref020]--[@pone.0187542.ref022]\]. Third, they differ in their patterns of growth and in metabolic/fermenting capacities \[[@pone.0187542.ref008], [@pone.0187542.ref021], [@pone.0187542.ref023]\]. LS25 has been shown to ferment a larger variety of carbohydrates than 23K and to grow faster on ribose. Also, LS25 seems to be a faster acid producer which shows better abilities as a starter culture based on acidification properties in a meat model and its ability to compete with the indigenous microbiota of meat batter, compared with 23K. We here investigate and compare how growth rate-dependent relative protein and gene transcript levels relate to the metabolic end-product formation profiles of the two *L*. *sakei* strains. The main goal was to unravel underlying molecular mechanisms involved in the response to reduced glucose availability.

Materials and methods {#sec002}
=====================

Bacterial strains and growth medium {#sec003}
-----------------------------------

*L*. *sakei* strain 23K is a plasmid-cured sausage isolate \[[@pone.0187542.ref017]\], and strain LS25 is a commercial starter culture strain for salami sausage \[[@pone.0187542.ref018]\]. The complete and a draft genome sequence have been published for 23K \[[@pone.0187542.ref001]\] and for LS25 \[[@pone.0187542.ref019]\], respectively. Both strains were grown in a chemically defined medium (CDM) which is specifically designed to support the growth of LAB \[[@pone.0187542.ref024], [@pone.0187542.ref025]\]. The viability of cells from the chemostat cultures was determined by conventional plating on agar plates of the rich De Man, Rogosa and Sharpe (MRS) medium (Oxoid) and grown at 30°C for 48 h.

Chemostat cultures {#sec004}
------------------

Anaerobic glucose-limited chemostat cultures were grown in 300-ml fermenter vessels (Soham Scientific) with a total volume of 280 ml culture under continuous stirring. The temperature was kept at 30°C and the pH kept constant at pH 6.5 by automatic addition of 2 M NaOH. Growth rates of the steady-states were controlled by the culture dilution rates (*D*) set at 0.045 h^-1^ (henceforth also referred to as low growth rate) and 0.357 h^-1^ (high growth rate). The inoculum for each chemostat culture was prepared through two 10-mL subcultures for 16 h each, with a transfer volume of 5% (vol vol^-1^). After batch growth until an optical density at 600 nm (OD~600~) of around 2 was reached, fresh medium was pumped at the appropriate flow. The cultures were considered to be in steady-state since no detectable glucose remained in the culture supernatant and the ODs, dry weights, and product concentrations of the cultures were constant over two consecutive days. All experiments were performed in triplicate, resulting in sets of 12 samples (2 strains, 2 growth rates, 3 biological replicates) for further analyses.

Sampling {#sec005}
--------

The chemostat cultures were grown for six generations before sampling. Biomass was monitored by measuring the OD~600~, and biomass dry weight was determined gravimetrically. For proteomic analysis, cells were harvested by centrifugation at 2800 x *g* at 4°C and washed twice in 0.01 M Tris-HCl pH 7.5 for 15 min before storage at -80°C. Supernatants were frozen at -20°C until metabolite analysis. For transcriptomic analysis, samples (3 ml) were collected and added RNA Protect Bacteria Reagent (Qiagen) (6 ml), vortexed for 5 sec, incubated at room temperature for 5 min, centrifuged for 10 min at 3700 x *g*, before the pellet was stored at -80°C for later RNA purification.

Metabolite analysis {#sec006}
-------------------

**S**upernatant samples were filtered through a 0.22 μm Millex-HV Durapore PVDF filter (Millipore), and extracellular concentrations of glucose, pyruvate, lactate, formate, acetate, succinate, acetoin, butanediol and ethanol were analyzed on an Agilent 1100 series high-pressure liquid chromatography (HPLC) system (Agilent Technologies) equipped with an auto sampler cooled to 4°C, a diode array detector (DAD), and a RI 132 refractive index (Gilson) detector. A Rezex organic acid analysis column (Phenomenex) at a temperature of 45°C with 7.2 mM H~2~SO~4~ as the eluent was used as previously described \[[@pone.0187542.ref024]\]. ChemStation chromatography software (Agilent) was used for data integration, and concentrations were estimated by comparison of peak areas to a calibration curve obtained with standards analyzed under the same conditions.

The extracellular concentration in the filtered supernatants of alanine, arginine, aspartic acid, asparagine, citrulline, glutamic acid, glutamine, glycine, histidine, isoleucine, leucine, lysine, methionine, ornithine, phenylalanine, serine, threonine, tryptophan, tyrosine, and valine were determined by liquid chromatography with fluorescence detection (350 nm excitation, 450 nm emission, RF 20-A, Shimadzu, 's-Hertogenbosch, The Netherlands) as detailed elsewhere \[[@pone.0187542.ref026]\]. The method is based on a precolumn derivatization protocol with ortho-phtalaldehyde and 3-mercaptopropionic acid, using 1 mM of DL-norvaline as an internal standard. Compounds listed were quantified by comparison of peak areas against normalized individual calibration lines obtained under the same conditions.

Protein extraction and NanoLC-ESI-LTQ Orbitrap Velos Pro mass spectrometry analysis {#sec007}
-----------------------------------------------------------------------------------

Extraction of soluble proteins from 10 ml samples of the cultures was performed as previously described by McLeod *et al*. (8). The protein concentration of the cytosolic fraction was determined using the colorimetric assay *RC DC* Protein Assay (Bio-Rad), with bovine serum albumin (BSA) as standard protein, according to the manufacturer's instructions. Trypsin digested samples (\~0.5 μg) were loaded in randomized order onto a pre-column (Dionex, Acclaim PepMap Nano Trap column, C18, 75 μm i.d. x 2 cm, 3 μm) followed by separation on an analytical column (Dionex, Acclaim PepMap100 RSLCnano column, 75 μm x 15 cm, C18, 2 μm) using a Dionex Ultimate NCS-3500RS LC system (Sunnyvale, CA) coupled online to an Orbitrap Velos Pro (Thermo Scientific) mass spectrometer (MS). A linear gradient of 90 minutes was used with mobile phase A (0.1% formic acid / 2% acetonitrile) and mobile phase B (0.1% formic acid / 90% acetonitrile) ramping from 8--38% mobile phase B, and the peptides were continuously eluted into the Orbitrap MS. Data dependent acquisition was used in collision-induced dissociation-mode, where the MS continuously sequenced the 7 ions with highest intensity eluting from the column during the gradient. The raw spectra from the Orbitrap were loaded into Progenesis LC-MS v4.0 (<http://www.nonlinear.com/products/progenesis/lc-ms/overview/>), and retention time aligned to correlate precursor and potential fragment ion spectra across samples. Spectra were centroided, deisotoped and charge-state-reduced to produce a single accurately mass measured monoisotopic mass for each peptide and the associated fragment ions. The data were combined in a merge file and searched against *L*. *sakei* using SeachGUI \[[@pone.0187542.ref027]\]. The search was open in PeptideShaker (<https://code.google.com/p/peptide-shaker/>) and the identified proteins were transported back to Progenesis to fulfill the labelfree analysis (peptide FDR = 1.0%). Normalized abundance values followed by log~2~ transformation were used as inputs in statistical analyses.

RNA isolation, mRNA enrichment, cDNA synthesis and RNA sequencing {#sec008}
-----------------------------------------------------------------

Total RNA was extracted from bacterial cells using the RNeasy Mini Kit (Qiagen) as described by Rud *et al*. \[[@pone.0187542.ref028]\]. The RNA was quantified spectrophotometrically (NanoDrop ND-1000; NanoDrop Technologies), and quality and purity were verified using an Agilent 2100 Bioanalyzer (Agilent Technologies). Sample criteria were A260/A280 ratio \>1.9; A260/A280 ratio ∼2.0; 23S/16S RNA ratio \>1.3; RIN\>8.0 for use in the transcriptome analysis. The MICROBExpress™ Bacterial mRNA Enrichment Kit (Ambion, Life Technologies) was used for the selective removal of 16S and 23S rRNA with oligonucleotide probes attached to magnetic beads according to the manufacturer's protocol. Furthermore, enriched mRNA yields were analyzed using NanoDrop ND-1000 and Agilent 2100 Bioanalyzer, before generation of cDNA sequencing libraries with the Illumina TruSeq RNA Sample Prep Kit following instructions from the supplier (Illumina Netherlands BV, \#RS-122-2001). The mRNA is by this procedure fragmented into small pieces using divalent cations under elevated temperature, copied into first strand cDNA using SuperScript® II Reverse Transcriptase and random primers (Invitrogen). This is followed by second strand cDNA synthesis using DNA polymerase I and RNase H. The cDNA fragments then go through an end repair process, the addition of a single 'A' base, and then ligation of RNA adapters index (barcoding). The products are purified and enriched with PCR to create the final cDNA library. Agencourt AMPure XP (Beckman Coulter, \#A63880) solid-phase paramagnetic bead technology was used for the purification of PCR amplicons. Double-stranded cDNA was quantified and the quality and purity were verified using the NanoDrop ND-1000 and the Agilent 2100 Bioanalyzer, respectively. The cDNA libraries were sequenced (50 bp read length, 12-plex, one lane) on a HiSeq system (Illumina). The raw reads have been deposited to the National Center for Biotechnology Information (NCBI) Sequence Read Archive (SRA) under accession number PRJNA393246.

RNA sequencing-based transcriptome data {#sec009}
---------------------------------------

First, the software bowtie \[[@pone.0187542.ref029]\] was used to construct a reference database from each of the two strains in the study, consisting of 1963 and 2027 annotated genes for *L*. *sakei* strain 23K \[[@pone.0187542.ref001]\] and strain LS25 \[[@pone.0187542.ref019]\], respectively. Next, reads in fastq formatted files were mapped to the corresponding reference database using the command line "bowtie -n 2---trim5 10 --best \<filenames\>", which means we allow up to 2 mismatches and trim each read with 10 nt in the 5-end. The latter was due to a quality inspection of the reads using the FastQC software (<http://www.bioinformatics.babraham.ac.uk/projects/fastqc/>). The counts for each strain were arranged in a matrix of N rows (N = 1963 for 23K, N = 2027 for LS25) and 6 columns, where 3 of the columns are data from low and 3 from high growth rate conditions, using the software R (<http://www.r-project.org/>). The 16S and 23S rRNA-genes usually consume the majority of the sequencing depth in microbial RNAseq samples, and the total number of reads mapped in each sample is very sensitive to these genes. Despite selective removal of the 16S and 23S rRNA using the MICROBExpress™ Bacterial mRNA Enrichment Kit, these loci still influence largely and were therefore discarded from the data set. The read counts were converted to RPKM-values (Reads Per Kilobase gene per Million mapped reads) in the Nx6 matrices described above, followed by log~2~ transformation before being used as inputs in statistical analyses.

Data exploration and statistical analyses {#sec010}
-----------------------------------------

Effects of strains and growth condition for the phenotypic end-product profiles (henceforth also referred to as phenome) were defined by F-test in analysis of variance for lactate, formate, ethanol and acetate after adjusting p-value by False Discovery Rate (FDR) using the rotation test described by Langsrud *et al*. \[[@pone.0187542.ref030]\]. Similar approach was used to define effects of strains and growth condition for the amino acids. The tests were performed in R using the package ffmanova (<https://CRAN.R-project.org/package=ffmanova>). For the proteome (abundance values, log~2~ transformed) and transcriptome (RPKM-values, log~2~ transformed), with focus on common genes for both strains, predictions of the end-product phenotype were performed with variable selection by the multivariate elastic net method \[[@pone.0187542.ref031]\] using the glmnet package in R (<https://CRAN.R-project.org/package=glmnet>). Elastic net combines the merits of ridge regression (known also as Tikhonov regularization) and the Lasso method \[[@pone.0187542.ref032], [@pone.0187542.ref033]\]. First, the ridge regression coefficients for all variables multiplying the estimated coefficients are found, and second, a Lasso type shrinkage is performed. The method was repeated 1000 times using alpha tuning parameter 0.5, which gives a 50:50 weight to ridge regression and Lasso. The regularization parameter (lambda) was set to log.lambda.min. An explorative multivariate Principal Component Analysis (PCA) was performed within each data block (phenome, transcriptome and proteome) before and after elastic net feature extraction. To omit variables that only describe variation within the biological replicates, proteins and transcripts selected for the prediction of the phenotype were subjected to validation by univariate confidence intervals \[[@pone.0187542.ref034]\]. This was performed on the fold change difference within each strain.

Results {#sec011}
=======

Metabolite analyses revealed phenotypic strain differences {#sec012}
----------------------------------------------------------

For the two strains of *L*. *sakei*, 23K and LS25, cultivated under anaerobic conditions in glucose-limited chemostat cultures set at high (*D* = 0.357 h^-1^) and low (*D* = 0.045 h^-1^) dilution rates, glucose was completely consumed throughout cultivation. All chemostat results showed a carbon balance above 95% on the basis of glucose consumption and organic acid formation ([Table 1](#pone.0187542.t001){ref-type="table"}). The reduction in glucose availability from high to low growth rate resulted in a significantly changed end-product profile (phenome) for both strains ([S1 Table](#pone.0187542.s001){ref-type="supplementary-material"}), though the dominating products were lactate\>formate\>acetate≥ethanol at both conditions ([Fig 1](#pone.0187542.g001){ref-type="fig"}). The shifts in metabolism is illustrated with PCA for mean centred standardised data ([Fig 2](#pone.0187542.g002){ref-type="fig"}). PC1 captured as much as 99% of the total variation in the data set, separating the samples from high vs low growth rate in the score plot ([Fig 2](#pone.0187542.g002){ref-type="fig"}, left), clearly more pronounced for strain LS25 than for 23K ([S1 Table](#pone.0187542.s001){ref-type="supplementary-material"}), and the correlating end-products in the loading plot ([Fig 2](#pone.0187542.g002){ref-type="fig"}, right). High growth rate correlated with lactate, reflecting homolactic fermentation, while low growth rate correlated with aceate, formate and ethanol, reflecting a more mixed acid profile. The lactate flux decreased stronger for LS25 compared with 23K from high to low growth rate ([Table 1](#pone.0187542.t001){ref-type="table"}), and the end-product formations (mol per mol glucose) illustrated the highest relative change for formate for LS25, which increased 75.1% compared to 49.3% in 23K ([Fig 1](#pone.0187542.g001){ref-type="fig"}). The biomass concentration decreased from high to low growth rate for both strains. The dry weight decreased by 31.15% and 29.21% ([Table 1](#pone.0187542.t001){ref-type="table"}), and the OD~600~ by 24.1% and 17.1% for 23K and LS25, respectively. We did not observe any significant differences in the percentage of viable cells within these populations (data not shown).

![*L*. *sakei* end-product formation at high and low glucose availability.\
Mol end-product (lactate; blue, formate; red, acetate; green, ethanol; orange) per mol glucose for *L*. *sakei* strains 23K and LS25 grown at high (*D* = 0.357 h^-1^) and low (*D =* 0.045 h^-1^) dilution rates in continuous glucose-limited chemostats. Percent (%) change in mol of end-product per mol of glucose between the growth rates is indicated.](pone.0187542.g001){#pone.0187542.g001}

![PCA on the phenome.\
PCA on the phenome end-products mean centered and standardized to unit variance. Score plot (left) and loading plot (right) on PC1 (x-axis) vs PC2 (y-axis). *L*. *sakei* strains 23K and LS25 are shown in blue and red, respectively. Squares indicate high growth rate and high glucose availability. Open triangles indicate low growth rate and restricted glucose availability.](pone.0187542.g002){#pone.0187542.g002}

10.1371/journal.pone.0187542.t001

###### Metabolite production, carbon flux and carbon flux/growth rate in *L*. *sakei* during continuous cultivation in glucose-limited CDM-LAB medium.

![](pone.0187542.t001){#pone.0187542.t001g}

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Strain                     Dilution rate, h^-1^   Dry Weight\                                                         Lactate[^a^](#t001fn001){ref-type="table-fn"}   Formate[^a^](#t001fn001){ref-type="table-fn"}   Acetate[^a^](#t001fn001){ref-type="table-fn"}   Ethanol[^a^](#t001fn001){ref-type="table-fn"}   \% Carbon balance[^a^](#t001fn001){ref-type="table-fn"}^,^ [^b^](#t001fn002){ref-type="table-fn"}
                                                    (dW) g/liter[^a^](#t001fn001){ref-type="table-fn"}                                                                                                                                                                                                                  
  -------------------------- ---------------------- ---------------------------------------------------- -------------- ----------------------------------------------- ----------------------------------------------- ----------------------------------------------- ----------------------------------------------- ---------------------------------------------------------------------------------------------------
  \                          \                      \                                                    Conc (mM)      91.78 (0.63)                                    15.13 (1.22)                                    10.57 (1.15)                                    7.91 (0.56)                                     98.32 (0.65)
  23K\                       0.357\                 1.83 (0.01)\                                                                                                                                                                                                                                                        

  Flux (mmol h^-1^) dW^-1^   17.84 (0.12)           2.94 (0.24)                                          2.06 (0.22)    1.54 (0.11)                                                                                                                                                                                     

  mmol g^-1^                 49.96 (0.34)           8.24 (0.66)                                          5.76 (0.62)    4.30 (0.30)                                                                                                                                                                                     

  \                          \                      Conc (mM)                                            76.25 (4.09)   29.85 (3.88)                                    20.25 (3.15)                                    15.28 (1.19)                                                                                    
  0.045\                     1.26 (0.09)\                                                                                                                                                                                                                                                                               

  Flux (mmol h^-1^) dW^-1^   2.72 (0.15)            1.06 (0.14)                                          0.72 (0.11)    0.54 (0.04)                                     99.00 (0.56)                                                                                                                                    

  mmol g^-1^                 60.34 (3.24)           23.62 (3.07)                                         16.03 (2.49)   12.09 (0.94)                                                                                                                                                                                    

  \                          \                      \                                                    Conc (mM)      96.00 (1.79)                                    11.61 (1.78)                                    8.01 (1.03)                                     6.93 (2.36)                                     
  LS25\                      0.357\                 1.78 (0.04)\                                                                                                                                                                                                                                                        

  Flux (mmol h^-1^) dW^-1^   19.23 (0.36)           2.33 (0.36)                                          1.61 (0.21)    1.39 (0.47)                                     98.95 (1.31)                                                                                                                                    

  mmol g^-1^                 53.88 (1.00)           6.52 (1.00)                                          4.50 (0.58)    3.89 (1.32)                                                                                                                                                                                     

  \                          \                      Conc (mM)                                            56.75 (0.47)   46.55 (0.20)                                    26.27 (0.14)                                    24.77 (0.89)                                                                                    
  0.045\                     1.26 (0.07)\                                                                                                                                                                                                                                                                               

  Flux (mmol h^-1^) dW^-1^   2.01 (0.02)            1.65 (0.01)                                          0.93 (0.01)    0.88 (0.03)                                     95.75 (0.37)                                                                                                                                    

  mmol g^-1^                 44.75 (0.37)           36.70 (0.15)                                         20.71 (0.11)   19.53 (0.70)                                                                                                                                                                                    
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

^a^Standard deviation is shown in parentheses

^b^The CDM-LAB medium contained 55.5 mM glucose

Differences in consumption of certain amino acids were observed ([S1](#pone.0187542.s001){ref-type="supplementary-material"} and [S2](#pone.0187542.s002){ref-type="supplementary-material"} Tables). Alanine, lysine, and glutamine consumption decreased at low compared with high growth rate, however the changes were minor for the latter two amino acids. A simultanous increase was seen in threonine and tryptophan consumption, which was minor for the latter amino acid. The only amino acid for which the two strains responded differently upon changed growth condition, was threonine. 23K cells consumed more than 95% of threonine at both growth rates, whereas LS25 consumed approximately 73% during fast and 95% during slow growth. Strain differences regardless of growth rate was also observed. 23K consumed most of the arginine present in the growth medium, more than 93% at both growth rates, whereas LS25 consumed less than 52%. Parallel to the consumption of arginine, small amounts of citrulline and ornithine were detected for both strains, of which higher concentrations were observed for 23K ([S3 Table](#pone.0187542.s003){ref-type="supplementary-material"}). These data reflect the activity of the arginine deiminase (ADI) pathway, in which arginine is converted via citrulline into ornithine, ammonia and CO~2~ with production of ATP \[[@pone.0187542.ref010], [@pone.0187542.ref011], [@pone.0187542.ref035]--[@pone.0187542.ref037]\]. About 98--99% of asparagine and glutamine were consumed by both strains at both growth rates, and 96% of serine ([S2 Table](#pone.0187542.s002){ref-type="supplementary-material"}).

Proteome and transcriptome profiling {#sec013}
------------------------------------

The effects of glucose availability on the proteome and transcriptome, hence growth rate-dependent relative protein and gene transcript levels, were investigated. The proteome was analyzed using high-resolution LTQ-Orbitrap mass spectrometry, where peptides of 756 and 906 cytoplasmic proteins were detected in all the 6 samples of 23K and LS25, respectively, and used for quantitation for each strain. Subsequent analysis of gene transcripts by RNA sequencing (RNA-seq) was performed, and for 23K and LS25 (excluding 23S and 16S genes), 99.9% and 99.7% of the genes were accounted for, respectively. The average number of reads per gene were 1124 and 642, median number of reads per gene were 179 and 172, and the average coverage per base inside genes were 84x and 47x for 23K and LS25, respectively. A complete set of proteome and transcriptome log~2~ transformed data can be found in [S4 Table](#pone.0187542.s004){ref-type="supplementary-material"}.

By a multivariate approach, we analyzed how the proteome and transcriptome data relate to the changes in the phenome end-product profile. PCA on the proteome ([Fig 3](#pone.0187542.g003){ref-type="fig"}) distinguished well the effects of strain, PC1 explained by 81%, and the effects of growth rate, PC2 explained by 11%. PCA on the transcriptome ([Fig 3](#pone.0187542.g003){ref-type="fig"}) also defined the two strains as the most important variation in the data, with PC1 explained by 65%. The effect of growth rate shown in PC2 of the transcriptome was explained by 9%, and reflected differences between biological replicates as well. The expression of the majority of transcripts were higher for LS25 than for 23K (left side of the PCA loading plot, [Fig 3](#pone.0187542.g003){ref-type="fig"}). Further PC's only implied differences within biological replicates ([S1](#pone.0187542.s005){ref-type="supplementary-material"} and [S2](#pone.0187542.s006){ref-type="supplementary-material"} Figs). Neither PCA of the proteome, nor of the transcriptome, reflected the same interaction pattern between strain and growth condition as seen for the phenome ([Fig 2](#pone.0187542.g002){ref-type="fig"} and [S1 Table](#pone.0187542.s001){ref-type="supplementary-material"}). This suggested that the interaction pattern observed for the phenome with a stronger change for LS25 than for 23K was not associated with a corresponding variation in a large number of proteins nor transcripts. A minor group of proteins and transcripts were identified as relevant for the prediction of the phenome using supervised multivariate analysis by elastic net ([S3 Fig](#pone.0187542.s007){ref-type="supplementary-material"}), and univariate validation by confidence interval was used for omission of those that only described variation within biological replicates. PCA performed after this feature selection reflected similar pattern of variation as seen for the phenome, both for the proteins and for the transcripts ([Fig 4](#pone.0187542.g004){ref-type="fig"}, left), with a larger shift for LS25 than for 23K along the first PC. The selected features were assigned to 4 groups with similar pattern along the two first PCs ([Fig 4](#pone.0187542.g004){ref-type="fig"}, right). Plots of selected features log~2~ transformed data can be found in [S4 Fig](#pone.0187542.s008){ref-type="supplementary-material"} (proteome) and [S5 Fig](#pone.0187542.s009){ref-type="supplementary-material"} (transcriptome).

![PCA on all features of the proteome and transcriptome.\
PCA of the proteome (all 643 variables) and transcriptome (all 1632 variables) mean centered and standardized to unit variance. Score plots (left) and loading plots (right) on PC1 (x-axis) vs PC2 (y-axis). *L*. *sakei* strains 23K and LS25 are shown in blue and red, respectively. Squares indicate high growth rate and high glucose availability. Open triangles indicate low growth rate and restricted glucose availability.](pone.0187542.g003){#pone.0187542.g003}

![PCA of proteins and gene transcripts after variable selection towards the phenome.\
Proteins and gene transcripts selected by elastic net (left), where *L*. *sakei* strains 23K and LS25 are shown in blue and red, respectively. Squares indicate high growth rate and high glucose availability. Open triangles indicate low growth rate and restricted glucose availability. The selected proteins and transcripts were assigned to 4 groups with similar pattern (right), indicated in green, orange, black and red for groups 1--4, respectively.](pone.0187542.g004){#pone.0187542.g004}

Proteins with altered level of expression from high to low growth rate are presented in [Table 2](#pone.0187542.t002){ref-type="table"} and transcripts are presented in [Table 3](#pone.0187542.t003){ref-type="table"}. Mean expression of the pattern of variation within each of the groups are illustrated in [Fig 5](#pone.0187542.g005){ref-type="fig"}.

![Mean expression of selected proteins and gene transcripts that responded to changed glucose availability in *L*. *sakei*.\
Expression of selected proteins (P) and gene transcripts (T) as mean values within each group (1--4) are according to Tables [2](#pone.0187542.t002){ref-type="table"} and [3](#pone.0187542.t003){ref-type="table"}, respectively. Groups are defined by the PCs in the PCA shown in [Fig 4](#pone.0187542.g004){ref-type="fig"}. *L*. *sakei* strain 23K is shown in blue and strain LS25 in red. Squares indicate high growth rate and high glucose availability (H). Open triangles indicate low growth rate and restricted glucose availability (L).](pone.0187542.g005){#pone.0187542.g005}

10.1371/journal.pone.0187542.t002

###### Proteins explaining *L*. *sakei* strain differences in phenome end-product profiles from high to low growth rate.

Fold change from high to low growth rate and simple correlation coefficient (*r*) between selected protein and each end-product are shown. The proteins are assigned to 4 groups with similar pattern (Figs [4](#pone.0187542.g004){ref-type="fig"} and [5](#pone.0187542.g005){ref-type="fig"}; [S4 Fig](#pone.0187542.s008){ref-type="supplementary-material"}).

![](pone.0187542.t002){#pone.0187542.t002g}

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
             *L*. *sakei* locus tag                                                                         Fold change[^a^](#t002fn001){ref-type="table-fn"}   Correlation, *r*                                       
  ---------- ------------------------ --------------------------------------------------------------------- --------------------------------------------------- ------------------ ----------- ------- ------- ------- -------
  \          LCA_0316                 LS25_0363                                                             L-serine dehydratase subunit beta (SDH)             0.38               **1.36**    -0.89   0.88    0.81    0.90
  **1**\                                                                                                                                                                                                               

  LCA_0848   LS25_0936                Redox-sensing transcriptional repressor Rex                           0.41                                                **1.23**           -0.93       0.93    0.89    0.96    

  LCA_0974   LS25_1064                Formate C-acetyltransferase (PFL)                                     **0.91**                                            **1.67**           -0.90       0.90    0.84    0.93    

  \          LCA_0802                 LS25_0894                                                             NADH oxidase (Nox)                                  **0.74**           **1.09**    -0.95   0.94    0.93    0.95
  **2**                                                                                                                                                                                                                

  LCA_1154   LS25_1251                Hypothetical protein                                                  **0.47**                                            **0.45**           -0.85       0.86    0.88    0.83    

  LCA_1881   LS25_0004                Putative single-stranded nucleic acid binding protein                 **0.64**                                            **0.54**           -0.88       0.88    0.90    0.88    

  \          LCA_0088                 LS25_0092                                                             Adenine deaminase                                   -0.59              **-2.11**   0.86    -0.86   -0.83   -0.87
  **3**\                                                                                                                                                                                                               

  LCA_1099   LS25_1198                Folylpolyglutamate synthase                                           0.07                                                **-0.54**          0.60        -0.60   -0.53   -0.61   

  LCA_1440   LS25_1514                CutC family copper homeostasis protein                                -0.12                                               **-0.74**          0.87        -0.87   -0.82   -0.86   

  LCA_1467   LS25_1541                Hypothetical protein                                                  -0.53                                               **-2.09**          0.89        -0.88   -0.83   -0.89   

  LCA_1559   LS25_1643                Putative oxidoreductase                                               -0.29                                               **-0.87**          0.87        -0.87   -0.84   -0.87   

  LCA_1573   LS25_1658                Putative teichoic acid/polysaccharide glycosyl transferase, group 1   -0.15                                               **-0.54**          0.89        -0.89   -0.87   -0.85   

  LCA_1879   LS25_0002                Cell division protein GidA                                            -0.11                                               **-1.01**          0.79        -0.78   -0.73   -0.75   

  \          LCA_0830                 LS25_0920                                                             Inosine-uridine preferring nucleoside hydrolase     **-0.71**          **-0.60**   0.75    -0.75   -0.81   -0.74
  **4**\                                                                                                                                                                                                               

  LCA_0914   LS25_1000                Asparaginyl-tRNA synthetase                                           -0.05                                               **-0.41**          0.86        -0.86   -0.86   -0.83   

  LCA_1373   LS25_1447                Uridine kinase                                                        -0.37                                               **-0.45**          0.83        -0.84   -0.88   -0.83   

  LCA_1421   LS25_1495                Arginyl-tRNA synthetase                                               **-0.45**                                           **-0.48**          0.82        -0.83   -0.88   -0.78   

  LCA_1552   LS25_1635                ATP-dependent DNA helicase                                            **-0.54**                                           **-0.77**          0.58        -0.59   -0.70   -0.52   

  LCA_1878   LS25_0001                Putative drug resistance ABC transporter, two ATP-binding subunits    -0.41                                               **-0.72**          0.69        -0.70   -0.77   -0.62   
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

^a^Significant (p\<0.05) fold change values are shown in bold writing

10.1371/journal.pone.0187542.t003

###### Gene transcripts explaining *L*. *sakei* strain differences in phenome end-product profiles from high to low growth rate.

Fold change from high to low growth rate and simple correlation coefficient (*r*) between selected transcript and each end-product are shown. The transcripts are assigned to 4 groups with similar pattern (Figs [4](#pone.0187542.g004){ref-type="fig"} and [5](#pone.0187542.g005){ref-type="fig"}; [S5 Fig](#pone.0187542.s009){ref-type="supplementary-material"}).

![](pone.0187542.t003){#pone.0187542.t003g}

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                                   *L*. *sakei* locus tag                                                                              Fold change[^a^](#t003fn001){ref-type="table-fn"}                                 Correlation, *r*                                       
  ------------------------------------------------ ------------------------ -------------------------------------------------------------------------- --------------------------------------------------------------------------------- ------------------ ----------- ------- ------- ------- -------
  \                                                LCA_0195                 LS25_0201                                                                  Hypothetical lipoprotein precursor                                                -0.49              **1.95**    -0.69   0.68    0.57    0.72
  **1**\                                                                                                                                                                                                                                                                                        

  LCA_0777                                         LS25_0869                Hypothetical protein                                                       0.40                                                                              **1.78**           -0.79       0.78    0.76    0.75    

  LCA_0802                                         LS25_0894                NADH oxidase (*nox*)                                                       0.15                                                                              **0.84**           -0.73       0.72    0.64    0.73    

  LCA_0831                                         LS25_0922                Putative nitroreductase, oxidoreductase                                    **-0.87**                                                                         **2.45**           -0.70       0.68    0.61    0.65    

  LCA_0897                                         LS25_0973                Dipeptidase D-type, U34 family (*pepD5*)                                   -0.08                                                                             **2.17**           -0.78       0.77    0.74    0.73    

  LCA_0930                                         LS25_1015                Putative ABC transporter, ATP-binding subunit                              **-0.58**                                                                         **2.26**           -0.67       0.66    0.64    0.63    

  LCA_1190                                         LS25_1281                Putative 4-carboxymuconolactone decarboxylase                              -0.01                                                                             **1.12**           -0.77       0.76    0.70    0.78    

  LCA_1191                                         LS25_1282                Hypothetical protein                                                       0.32                                                                              **1.67**           -0.86       0.85    0.79    0.87    

  LCA_1192                                         LS25_1283                Putative transcriptional regulator, MerR family                            -0.17                                                                             **3.24**           -0.76       0.75    0.73    0.74    

  LCA_1193                                         LS25_1284                Putative oxidoreductase                                                    0.64                                                                              **2.15**           -0.84       0.83    0.79    0.84    

  LCA_1287                                         LS25_1358                Hypothetical cell surface protein                                          **-0.95**                                                                         **1.62**           -0.59       0.57    0.46    0.59    

  LCA_1512                                         LS25_1594                Putative polysaccharide biosynthesis protein, chain length determination   **-1.08**                                                                         **1.81**           -0.55       0.53    0.48    0.50    

  \                                                LCA_0509                 LS25_0572                                                                  2-amino-3-ketobutyrate CoA ligase (*kbl*)                                         **2.34**           **2.34**    -0.83   0.84    0.81    0.85
  **2**\                                                                                                                                                                                                                                                                                        

  LCA_0510[^b^](#t003fn002){ref-type="table-fn"}   LS25_0573                L-threonine dehydrogenase                                                  **1.81**                                                                          **2.43**           -0.88       0.89    0.87    0.89    

  LCA_0742                                         LS25_0798                Transcriptional regulator MraZ                                             0.62                                                                              **1.73**           -0.73       0.72    0.74    0.68    

  LCA_0743                                         LS25_0799                Putative S-adenosylmethionine-dependent-methyltransferase                  0.75                                                                              **1.90**           -0.74       0.73    0.72    0.68    

  LCA_1526                                         LS25_1609                Hypothetical protein                                                       0.59                                                                              **1.47**           -0.83       0.82    0.79    0.79    

  **3**                                            LCA_0202                 LS25_0208                                                                  Ribokinase (*rbsK*)                                                               -0.65              **-0.89**   0.67    -0.67   -0.63   -0.68

  \                                                LCA_0217                 LS25_0262                                                                  Putative thiosulfate sulfurtransferase with a ArsR-HTH domain, Rhodanese family   **-2.53**          **-1.07**   0.54    -0.56   -0.66   -0.51
  **4**\                                                                                                                                                                                                                                                                                        

  LCA_0705                                         LS25_0753                Oligopeptide ABC transporter ATP-binding subunit (*oppD*)                  **-4.10**                                                                         **-3.91**          0.70        -0.71   -0.79   -0.68   

  LCA_0706                                         LS25_0754                Oligopeptide ABC transporter ATP-binding subunit (*oppF*)                  **-4.31**                                                                         **-4.11**          0.69        -0.71   -0.79   -0.66   

  LCA_0788                                         LS25_0881                Putative MIP family facilitator protein                                    **-3.81**                                                                         -1.91              0.61        -0.63   -0.70   -0.61   

  LCA_0790                                         LS25_0883                Hypothetical protein                                                       **-3.79**                                                                         -2.48              0.69        -0.71   -0.77   -0.68   

  LCA_1787                                         LS25_1877                Hypothetical cell surface protein                                          **-2.47**                                                                         -1.50              0.69        -0.71   -0.76   -0.69   
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

^a^Significant (p\<0.05) fold change values are shown in bold writing

^b^N-terminal fragment, authentic frameshift

Proteome responses to reduced glucose availability {#sec014}
--------------------------------------------------

Proteins in group 1 and group 2 ([Fig 5](#pone.0187542.g005){ref-type="fig"}, [Table 2](#pone.0187542.t002){ref-type="table"} and [S4 Fig](#pone.0187542.s008){ref-type="supplementary-material"}) displayed elevated levels at low compared with high growth rate, and particularly for group 1 proteins, the increase was stronger for LS25 than for 23K. These proteins were positively correlated to formate, acetate and ethanol, and negatively correlated to lactate, thus they increased as the fermentation was directed towards mixed acid production. One of the proteins in group 1, formate C-acetyltransferase, often called pyruvate formate lyase (PFL), increased for both strains. This enzyme catalyzes the reversible conversion of pyruvate and Coenzyme-A (CoA) into formate and acetyl-CoA. Among all the selected proteins, PFL increased the most. Another protein in this group, L-serine dehydratase (SDH) is an enzyme composed of two subunits (beta and alpha, respectively) which may deaminate the amino acid serine to yield pyruvate with the release of ammonia (NH~3~). The level of SDH beta subunit increased strongly for LS25. Redox-sensing transcriptional repressor Rex also increased strongly for LS25. This gene regulator is known to respond to an elevated NADH/NAD^+^ ratio by differential binding to Rex operators \[[@pone.0187542.ref038]\]. Among the proteins in group 2 was NADH oxidase (Nox), which can reoxidize excess NADH formed \[[@pone.0187542.ref004]\]. This enzyme displayed an increased expression for both strains, more for LS25 than for 23K. Elevated levels were also seen for single stranded nucleic acid binding protein and a hypothetical protein.

Proteins in group 3 and group 4 ([Fig 5](#pone.0187542.g005){ref-type="fig"}, [Table 2](#pone.0187542.t002){ref-type="table"} and [S4 Fig](#pone.0187542.s008){ref-type="supplementary-material"}) displayed a reduction at low compared with high growth rate for LS25, and for some of the group 4 proteins also for 23K. The proteins in group 3 comprised adenine deaminase involved in purine metabolism, a hypothetical protein, cell division protein GidA, putative oxidoreductase, CutC family copper homeostasis protein, putative teichoic acid/polysaccharide glycosyl transferase and folylpolyglutamate synthase. Among the proteins in group 4, inosine-uridine preferring nucleoside hydrolase, involved in nucleoside catabolism and responsible for the conversion of inosine to ribose and a purine base, was affected in both strains, as was arginyl-tRNA synthetase and ATP dependent DNA helicase as well. For LS25, reduced expression was also seen for uridine kinase involved in pyrimidine metabolism, asparginyl-tRNA synthetase and putative drug resistance ABC transporter.

Transcriptome responses to reduced glucose availability {#sec015}
-------------------------------------------------------

At low compared with high growth rate, gene transcripts in group 1 ([Fig 5](#pone.0187542.g005){ref-type="fig"}, [Table 3](#pone.0187542.t003){ref-type="table"} and [S5 Fig](#pone.0187542.s009){ref-type="supplementary-material"}) showed strongly elevated levels for LS25, and simultaneously, no change or lower levels were seen for 23K. Genes encoding putative nitroreductase, putative ABC transporter, hypothetical cell surface protein and putative polysaccharide biosynthesis protein showed this pattern of regulation. In addition, for LS25, four upregulated genes seemed to be subjected to coordinated regulation, encoding putative 4-carboxymuconolactone decarboxylase, hypothetical protein, putative MerR family transcriptional regulator and putative oxidoreductase. The *nox* gene was also upregulated for LS25, and so were genes encoding hypothetical lipoprotein precursor, hypothetical protein and dipeptidase U34. Transcripts in group 2 ([Fig 5](#pone.0187542.g005){ref-type="fig"}, [Table 3](#pone.0187542.t003){ref-type="table"} and [S5 Fig](#pone.0187542.s009){ref-type="supplementary-material"}) showed increased levels. Increases for both strains were seen for *kbl* encoding the enzyme 2-amino-3-ketobutyrate CoA ligase, also named glycine C-acetyltransferase, which catalyzes the chemical reaction of acetyl-CoA and glycine into CoA and 2-amino-3-oxobutanoate and vice versa. Likely subjected to coordinated regulation with *kbl*, both strains also upregulated the gene encoding L-threonine dehydrogenase, that facilitates the catabolism of threonine by catalyzing conversion to glycine via 2-amino-3-ketobutyrate with concomitant reduction of NAD^+^. The gene is annotated with a nonsense mutation in 23K \[[@pone.0187542.ref001]\], confirmed by examining the RNA-seq reads (not shown), while it is complete in LS25 \[[@pone.0187542.ref019]\]. Moreover, for LS25, three more upregulated genes in group 2 encode hypothetical protein, transcriptional regulator MraZ and putative S-adenosylmethionine-dependent-methyltransferase, and the two latter seemed to be subjected to coordinated regulation.

Gene transcripts in group 3 and group 4 ([Fig 5](#pone.0187542.g005){ref-type="fig"}, [Table 3](#pone.0187542.t003){ref-type="table"} and [S5 Fig](#pone.0187542.s009){ref-type="supplementary-material"}) displayed lower levels at low compared with high growth rate. The group 3 gene *rbsK* encodes the ribokinase involved in ribose catabolism. Among genes in group 4, *oppD* and *oppF* were strongly downregulated for both strains. Opp is an ABC transporter encoded by the *oppABDCDF* operon, and is composed of substrate-binding lipoprotein OppA that binds extracellular peptides, two membrane-spanning transporter permeases, OppB and OppC, and two cytoplasmic ATPases, OppD and OppF. The gene encoding putative thiosulfate sulfurtransferase was also downregulated for both strains, whereas several transcripts displayed lower level only for 23K, including putative MIP family facilitator protein, hypothetical protein and hypothetical cell surface protein.

Discussion {#sec016}
==========

We have investigated the effect of glucose availability in *L*. *sakei* strains 23K and LS25 on the metabolite, proteome and transcriptome levels, where different degrees of response to the same energy restriction revealed strain specific regulation. Both strains shifted from homolactic fermentation at high growth rate towards more mixed acid fermentation at low growth rate, also observed by others \[[@pone.0187542.ref013], [@pone.0187542.ref016], [@pone.0187542.ref024], [@pone.0187542.ref039]\] and a common phenome in LAB \[[@pone.0187542.ref004]\]. However, the change was more pronounced for LS25 than for 23K with reduced glucose availability.

The observed metabolic change is attributed to an altered pyruvate metabolism which benefit the bacteria by generating ATP, or by gaining NAD^+^ for maintaining the redox balance, where various end-products in addition to lactate are produced \[[@pone.0187542.ref004]\]. Elevated production level of formate, more pronounced for LS25, was clearly reflected in the increased expression of PFL. Only active anaerobically, the PFL system \[[@pone.0187542.ref040], [@pone.0187542.ref041]\] was shown induced with lowering of the dilution rate in continuous culture systems also by others \[[@pone.0187542.ref026]\]. Between various organisms, shifts in metabolic strategies during growth are regulated in different ways, among which intracellular redox potential reflected by NADH/NAD^+^ ratio have been reported for LAB to be a key sensor \[[@pone.0187542.ref013], [@pone.0187542.ref042]\]. Various regulatory sensors monitor the redox state of all the cellular components for optimal overall function \[[@pone.0187542.ref043]\]. The transcriptional regulator Rex responds to NADH/NAD^+^ levels and negatively controls expression of genes involved in energy metabolism and fermentative growth in Gram-positive bacteria \[[@pone.0187542.ref038], [@pone.0187542.ref044]--[@pone.0187542.ref047]\]. Elevated protein level, stronger for LS25 than for 23K during slow growth, suggests this regulatory role for Rex. The commonality among the Rex-regulated enzymes is that they all function to maintain the NADH/NAD^+^ ratio needed to reposition the cells for re-entry into glycolysis. In response to carbohydrate limitations and/or high intracellular NADH/NAD^+^ level, the bacterial cells divert the catabolic pathways away from homofermentation towards mixed acid fermentation. Under low NADH/NAD^+^ ratio, Rex protein binds to the target sites and represses transcription of genes involved in NADH reoxidation, while the increase of NADH concentration results in the dissociation of Rex from DNA and thus derepression of its target genes \[[@pone.0187542.ref046], [@pone.0187542.ref048]\]. By comparative genomics approach, Ravcheev *et al*. \[[@pone.0187542.ref048]\] inferred 6 candidate Rex-binding sites located upstream of *L*. *sakei* target genes and operons. This included the Rex encoding gene, and among our selected features, the *nox* gene. Upregulated *nox* observed for LS25 during slow growth, as well as elevated Nox levels for both strains, but more pronounced for LS25, could imply regulation by Rex.

The observation that as much as 99% of the variation in the phenome could be accounted for by only one linear latent variable on the phenome level, with a stronger effect for LS25 than for 23K, suggests that a simple underlying mechanism could be controlling the effect. Potentially, there may be only one primary mechanism that secondary lead to coordinated changes. Rex is a candidate for such a primary effect. The elevated level of Nox is dually beneficial with alternative routes for NAD^+^ regeneration, and for detoxifying deleterious oxygen metabolites \[[@pone.0187542.ref001]\]. Despite a predilection for anaerobiosis, *L*. *sakei* is surprisingly well equipped to cope with changing oxygen and redox levels \[[@pone.0187542.ref001]\]. Several genes encoding proteins with oxidoreductase activity upregulated for LS25 also reflect the need to maintain the redox balance. A large arsenal of putative oxidoreductases with few homologs among lactobacilli are identified in *L*. *sakei*, indicating an efficient capacity for maintaining redox balance through tight control of the NADH/NAD^+^ ratio and the use of various electron acceptors \[[@pone.0187542.ref001]\].

Interestingly, our present experiment could be considered as an analog for *L*. *sakei* to the extensively studied topic of so-called complete calorie restricted diet, although in the present study glucose was the limiting factor. Complete caloric restriction is shown as a conserved mechanism in eukaryotes, from single-celled yeast to humans, to result in expanded healthy life span in response to a reduction of energy intake \[[@pone.0187542.ref049]--[@pone.0187542.ref052]\], and is found to act through mechanisms involving the redox balance \[[@pone.0187542.ref053]\]. For *L*. *sakei*, serine and threonine possibly enter the pyruvate pool after enzymatic conversion by SDH and L-threonine dehydrogenase at restricted glucose availability. Indeed, the level of SDH increased at low growth rate in LS25, and higher consumption of threonine was detected. The L-threonine dehydrogenase gene transcripts were upregulated in both strains at low growth rate. This gene contains a nonsense mutation in 23K \[[@pone.0187542.ref001]\]. However, the gene product(s) may still form an active enzyme. Complete caloric restricted diets in eukaryotes leads to elevated levels of gluconeogenic enzymes and transaminases of several amino acids \[[@pone.0187542.ref054]\], and specifically it has been shown that SDH is critical for serine utilization in gluconeogenesis \[[@pone.0187542.ref055]\].

An interesting difference between the two strains seemed to lay in the catabolism of arginine. Consumption of this amino acid and concominant production of citrulline and ornithine reflected the activity of the ADI pathway, seemingly more active in 23K than in LS25. The ability to utilize arginine as an energy source to generate ATP, which represents a competitive benefit in the low carbohydrate containing meat environment, has been thoroughly studied in *L*. *sakei*, however only for a few strains \[[@pone.0187542.ref010], [@pone.0187542.ref011], [@pone.0187542.ref035]--[@pone.0187542.ref037], [@pone.0187542.ref056], [@pone.0187542.ref057]\]. A second putative ADI pathway (LCA_0067--0073), present in 23K and suggested to further enhance its ability to survive in the meat environment \[[@pone.0187542.ref001]\], is not present in LS25 \[[@pone.0187542.ref019], [@pone.0187542.ref023]\]. By comparative genome hybridization using a microarray based on the 23K genome, this second putative ADI pathway was reported present in 10 of 18 *L*. *sakei* strains investigated \[[@pone.0187542.ref023]\]. Hence this second pathway may play a role in arginine catabolism under certain conditions. Mixed acid fermentation yields one extra ATP per glucose over homolactic fermentation \[[@pone.0187542.ref004]\]. Concominant with this higher ATP yield at slow growth, the bacterium also seemed to downregulate various pathways for saving energy, as seen for both strains in lower level of the ATP dependent helicase and proteins involved in purine/pyrimidine metabolism, as well as downregulation of genes encoding membrane proteins involved in oligopeptide uptake (*opp* genes) and glycerol uptake (MIP family facilitator protein). Biomass yield in *L*. *sakei* declined in slow growing cells. This might appear counterintuitive at first, since at slower growth rates cells adopt a metabolic strategy that results in a higher ATP yield per glucose consumed. However, this might not necessarily manifest itself as higher biomass yield since the gain in efficiency on the catabolism of the substrate, can be (and often is) offset by the increasing proportion of the cellular ATP requirements that get allocated from growth to maintenance (e.g. protein and nucleic acid repair) \[[@pone.0187542.ref058], [@pone.0187542.ref059]\].

It is clear from both the proteome and transcriptome changes in response to glucose availability that maintaining the redox balance is crucial for the optimum growth and survival of *L*. *sakei*. However, strain variation exists on how the redox and energy state are sensed and regulated to ensure an optimal outcome for the different cells. Investigations of a larger set of strains could elucidate whether the variation is strain-specific or specific to the two different subspecies, *carnosus* and *sakei*.

Supporting information {#sec017}
======================

###### Effects of strain, growth condition and interaction effects (strain\*growth) for end-products and amino acids.

*L*. *sakei* strains 23K and LS25 were grown in glucose-limited CDM-LAB medium at high and low growth rates. FDR-adjusted p-values are shown. Asterix (\*) indicates significant change (p.FDR\<0.05).

(PDF)

###### 

Click here for additional data file.

###### Amino acid consumption in *L*. *sakei* during continuous cultivation in glucose-limited CDM-LAB medium at different growth rates.

The consumption is shown in mM and %.

(PDF)

###### 

Click here for additional data file.

###### Production of citrulline and ornithine in *L*. *sakei* during continuous cultivation in glucose-limited CDM-LAB medium at different growth rates.

(PDF)

###### 

Click here for additional data file.

###### Proteome and transcriptome log~2~ transformed data.

*L*. *sakei* common genes, unique genes for strain 23K and unique genes for strain LS25 are listed by locus tags (LCA\_ for strain 23K and LS25\_ for strain LS25). Each sample set included 3 samples at high (H) and 3 samples at low (L) growth rate with 3 technical replicates (a, b, c) for the proteome (P) and transcriptome (T) analyses.

(XLSX)

###### 

Click here for additional data file.

###### PCA on all features of the proteome.

PCA of the proteome (all 643 variables) mean centered and standardized to unit variance. Score plots (left) and loading plots (right) on PC3 (x-axis) vs PC4 (y-axis) and PC5 (x-axis) vs PC6 (y-axis). *L*. *sakei* strains 23K and LS25 are shown in blue and red, respectively. Squares indicate high growth rate and open triangles indicate low growth rate.

(PDF)

###### 

Click here for additional data file.

###### PCA on all features of the transcriptome.

PCA of the transcriptome (all 1632 variables) mean centered and standardized to unit variance. Score plots (left) and loading plots (right) on PC3 (x-axis) vs PC4 (y-axis) and PC5 (x-axis) vs PC6 (y-axis). *L*. *sakei* strains 23K and LS25 are shown in blue and red, respectively. Squares indicate high growth rate and open triangles indicate low growth rate.

(PDF)

###### 

Click here for additional data file.

###### Elastic net coefficient and cross-validation curves.

Coefficient curves (left plots) display the coefficients of each variable (the proteome or the transcriptome) in different colors with increasing number of variables in the model as the regularization parameter and thereby the L1-norm (sum of the absolute value of regression coefficients) changes. Cross-validation curves (right plots) are displayed in red, upper and lower standard deviation curves in grey, for the prediction of the phenome (lactate, formate, acetate and ethanol) based on input variables. MSE refers to Mean Square Error.

(PDF)

###### 

Click here for additional data file.

###### Proteins that responded to changed glucose availability in *L*. *sakei*.

The proteins (P) are listed by 23K locus tag (LCA_XXXX), protein name and group according to [Table 2](#pone.0187542.t002){ref-type="table"}. Strains 23K and LS25 are shown in blue and red, respectively. Squares indicate high growth rate and open triangles indicate low growth rate. The proteins were selected by elastic net repeated 1000 times using alpha tuning parameter 0.5 and regularization parameter lambda set to log.lambda.min, followed by confidence intervals within each strain.

(PDF)

###### 

Click here for additional data file.

###### Gene transcript that responded to changed glucose availability in *L*. *sakei*.

The gene transcripts (T) are listed by 23K locus tag (LCA_XXXX), gene product name and group according to [Table 3](#pone.0187542.t003){ref-type="table"}. Strains 23K and LS25 are shown in blue and red, respectively. Squares indicate high growth rate and high glucose availability. Open triangles indicate low growth rate and restricted glucose availability. The gene transcripts were selected by elastic net repeated 1000 times using alpha tuning parameter 0.5 and regularization parameter lambda set to log.lambda.min, followed by confidence intervals within each strain.

(PDF)

###### 

Click here for additional data file.
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